- Patent Title: Methods of treatment using antibodies which bind IL-17A and IL-17F
-
Application No.: US14690892Application Date: 2015-04-20
-
Publication No.: US09988446B2Publication Date: 2018-06-05
- Inventor: Ralph Adams , Terence Seward Baker , Alastair David Griffiths Lawson
- Applicant: UCB Biopharma SPRL
- Applicant Address: BE Brussels
- Assignee: UCB BIOPHARMA SPRL
- Current Assignee: UCB BIOPHARMA SPRL
- Current Assignee Address: BE Brussels
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24
Abstract:
The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
Public/Granted literature
- US20150218271A1 ANTIBODY MOLECULES WHICH BIND IL-17A AND IL-17F Public/Granted day:2015-08-06
Information query
